GC
INSY

Globeflex Capital’s Insys Therapeutics, Inc. INSY Stock Holding History

Globeflex Capital’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-82,422
Closed -$758K – 600
2016
Q4 		$758K Buy
82,422
+42,798
+108% +$484K 0.19% 203
2016
Q3 		$467K Hold
39,624
– – 0.12% 254
2016
Q2 		$513K Sell
39,624
-16
-0% -$233 0.14% 234
2016
Q1 		$634K Hold
39,640
– – 0.17% 202
2015
Q4 		$1.14M Buy
39,640
+39,600
+99,000% +$1.1M 0.3% 116
2015
Q3 		$1K Sell
40
-10
-20% -$368 ﹤0.01% 474
2015
Q2 		$2K Sell
50
-18
-26% -$561 ﹤0.01% 412
2015
Q1 		$2K Sell
68
-10
-13% -$264 ﹤0.01% 406
2014
Q4 		$2K Sell
78
-98
-56% -$1.94K ﹤0.01% 410
2014
Q3 		$3K Sell
176
-144
-45% -$2.26K ﹤0.01% 398
2014
Q2 		$4K Buy
320
+42
+15% +$679 ﹤0.01% 411
2014
Q1 		$5K Sell
278
-232
-45% -$4.6K ﹤0.01% 376
2013
Q4 		$6K Hold
510
– – ﹤0.01% 378
2013
Q3 		$5K Buy
+510
New +$4.19K ﹤0.01% 383

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Globeflex Capital's INSY Position: Q1 2017 in Review

Globeflex Capital sold out of Insys Therapeutics, Inc. (INSY) in Q1 2017, closing a stake of 82,422 shares — an estimated $758K sold.

Globeflex Capital first reported a position in INSY in Q3 2013 and held it in 14 quarters. The position peaked at $1.14M in Q4 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q1 2017.

  • Globeflex Capital reported no remaining Insys Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Globeflex Capital sold 82,422 Insys Therapeutics, Inc. shares in Q1 2017, an estimated $758K.
  • Globeflex Capital first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 14 quarters.
  • Globeflex Capital's Insys Therapeutics, Inc. position peaked at $1.14M in Q4 2015.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2017.

Based on Globeflex Capital's 13F filing for Q1 2017, filed 12 May 2017.